Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Point32Health | Simponi (golimumab) Subcutaneous | New policy |
| Aug 2, 2026 | Point32Health | Simlandi (adalimumab-ryvk) | New policy |
| Aug 2, 2026 | Point32Health | Siliq (brodalumab) | New policy |
| Aug 2, 2026 | Point32Health | Siklos (hydroxyurea) | New policy |
| Aug 2, 2026 | Point32Health | Short Bowel Syndrome Agents | New policy |
| Aug 2, 2026 | Point32Health | Sedative Hypnotics Step Therapy | New policy |
| Aug 2, 2026 | Point32Health | Savella (milnacipran) | New policy |
| Aug 2, 2026 | Point32Health | Savella (milnacipran) | New policy |
| Aug 2, 2026 | Point32Health | Rytary (carbidopa & levodopa ER) Step Therapy | New policy |
| Aug 2, 2026 | Point32Health | Roflumilast tablets (Daliresp) | New policy |
| Aug 2, 2026 | Point32Health | Rinvoq (upadacitinib) | New policy |
| Aug 2, 2026 | Point32Health | Rifamycin Products | New policy |
| Aug 2, 2026 | Point32Health | Rhapsido (remibrutinib) | New policy |
| Aug 2, 2026 | Point32Health | Rhapsido (remibrutinib) | New policy |
| Aug 2, 2026 | Point32Health | Rezurock (belumosudil) | New policy |
| Aug 2, 2026 | Point32Health | Rezurock (belumosudil) | New policy |
| Aug 2, 2026 | Point32Health | Rezdiffra (resmetirom) | New policy |
| Aug 2, 2026 | Point32Health | Rezdiffra (resmetirom) | New policy |
| Aug 2, 2026 | Point32Health | Respiratory Inhalers | New policy |
| Aug 2, 2026 | Point32Health | Repository Corticotropin Injection | New policy |
| Aug 2, 2026 | Point32Health | Repository Corticotropin (Selfadministered) | New policy |
| Aug 2, 2026 | Point32Health | Redemplo (plozasiran) | New policy |
| Aug 2, 2026 | Point32Health | Rayaldee (calcifediol) | New policy |
| Aug 2, 2026 | Point32Health | Ravicti (glycerol phenylbutyrate) | New policy |
| Aug 2, 2026 | Point32Health | Ravicti (glycerol phenylbutyrate) | New policy |
| Aug 2, 2026 | Point32Health | Ranolazine Extended-Release Tablet | New policy |
| Aug 2, 2026 | Point32Health | Radicava ORS (edaravone) | New policy |
| Aug 2, 2026 | Point32Health | Radicava ORS (edaravone) | New policy |
| Aug 2, 2026 | Point32Health | RI Opioid Prescribing Limits | New policy |
| Aug 2, 2026 | Point32Health | RI Opioid Prescribing Limits | New policy |
| Aug 2, 2026 | Point32Health | Quinine | New policy |
| Aug 2, 2026 | Point32Health | Quantity Limit Exceptions | New policy |
| Aug 2, 2026 | Point32Health | Qbrexza (glycopyrronium) | New policy |
| Aug 2, 2026 | Point32Health | Qbrexza (glycopyrronium) | New policy |
| Aug 2, 2026 | Point32Health | Pulmonary Hypertension Medications | New policy |
| Aug 2, 2026 | Point32Health | Pulmonary Arterial Hypertension | New policy |
| Aug 2, 2026 | Point32Health | Proton Pump Inhibitors (PPIs) | New policy |
| Aug 2, 2026 | Point32Health | Proton Pump Inhibitors (PPIs) | New policy |
| Aug 2, 2026 | Point32Health | Progesterone Medications: (progesterone oil injectable; Crinone gel) | New policy |
| Aug 2, 2026 | Point32Health | Products with Quantity Limitations | New policy |
| Aug 2, 2026 | Point32Health | Primary Biliary Cholangitis (PBC) | New policy |
| Aug 2, 2026 | Point32Health | Primary Biliary Cholangitis (PBC) | New policy |
| Aug 2, 2026 | Point32Health | Priftin (rifapentine) | New policy |
| Aug 2, 2026 | Point32Health | Prevymis (letermovir) tablet | New policy |
| Aug 2, 2026 | Point32Health | Pretomanid Tablet | New policy |
| Aug 2, 2026 | Point32Health | Pregabalin (Lyrica) and Pregabalin extended-release (Lyrica CR) | New policy |
| Aug 2, 2026 | Point32Health | Platelet Aggregation Inhibitors | New policy |
| Aug 2, 2026 | Point32Health | Pilocarpine ophthalmic solution (Vuity) | New policy |
| Aug 2, 2026 | Point32Health | Pharmacy Products Without Specific Criteria | New policy |
| Aug 2, 2026 | Point32Health | Pegfilgrastim Products | New policy |